ATE435652T1 - Heterocarpine, ein pflanzliches protein mit antikrebs eigenschaften - Google Patents

Heterocarpine, ein pflanzliches protein mit antikrebs eigenschaften

Info

Publication number
ATE435652T1
ATE435652T1 AT03758268T AT03758268T ATE435652T1 AT E435652 T1 ATE435652 T1 AT E435652T1 AT 03758268 T AT03758268 T AT 03758268T AT 03758268 T AT03758268 T AT 03758268T AT E435652 T1 ATE435652 T1 AT E435652T1
Authority
AT
Austria
Prior art keywords
ile
gly
tyr
glu
val
Prior art date
Application number
AT03758268T
Other languages
English (en)
Inventor
Eric Ferrandis
Beng Teng
Christine Sohier
Christophe Thurieau
Original Assignee
Ipsen Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ipsen Pharma filed Critical Ipsen Pharma
Application granted granted Critical
Publication of ATE435652T1 publication Critical patent/ATE435652T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/13—Coniferophyta (gymnosperms)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Endocrinology (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT03758268T 2002-08-26 2003-08-25 Heterocarpine, ein pflanzliches protein mit antikrebs eigenschaften ATE435652T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0210560A FR2843697B1 (fr) 2002-08-26 2002-08-26 L'heterocarpine, une proteine d'origine vegetale aux proprietes anticancereuses
PCT/FR2003/002570 WO2004017987A2 (fr) 2002-08-26 2003-08-25 L'heterocarpine, une proteine d'origine vegetale aux proprietes anticancereuses

Publications (1)

Publication Number Publication Date
ATE435652T1 true ATE435652T1 (de) 2009-07-15

Family

ID=31198298

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03758268T ATE435652T1 (de) 2002-08-26 2003-08-25 Heterocarpine, ein pflanzliches protein mit antikrebs eigenschaften

Country Status (16)

Country Link
EP (1) EP1536808B1 (de)
JP (1) JP2006501229A (de)
KR (1) KR20050059091A (de)
CN (1) CN100406037C (de)
AT (1) ATE435652T1 (de)
AU (1) AU2003274281B2 (de)
BR (1) BR0313720A (de)
CA (1) CA2495972A1 (de)
DE (1) DE60328296D1 (de)
FR (1) FR2843697B1 (de)
IL (1) IL166461A0 (de)
MX (1) MXPA05002161A (de)
NZ (1) NZ537846A (de)
PL (1) PL375526A1 (de)
RU (1) RU2317097C2 (de)
WO (1) WO2004017987A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2520044T3 (es) 2007-03-30 2014-11-11 The Cleveland Clinic Foundation SDF-1 para su uso en el tratamiento de trastornos vasculares periféricos isquémicos
CA2709398C (en) 2007-12-14 2017-11-07 The Cleveland Clinic Foundation Use of stromal cell-derived factor 1 for promoting wound healing
MD3972C2 (ro) * 2009-03-11 2010-07-31 Ион МЕРЕУЦЭ Remediu şi metodă de tratament al stărilor precanceroase
JP5856059B2 (ja) * 2009-08-28 2016-02-09 ザ クリーブランド クリニック ファウンデーション 虚血組織を治療するためのsdf−1送達
US8403988B2 (en) 2009-09-11 2013-03-26 Depuy Spine, Inc. Minimally invasive intervertebral staple distraction devices
US9615933B2 (en) 2009-09-15 2017-04-11 DePuy Synthes Products, Inc. Expandable ring intervertebral fusion device

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2170589C2 (ru) * 1992-10-28 2001-07-20 Генентек Инк. Композиция для ингибирования ангиогенеза, моноклональное антитело, полипептид, способ ингибирования роста опухоли (варианты)
US5550212A (en) * 1993-12-17 1996-08-27 The Administrators Of The Tulane Educational Fund Analogues of hGH-RH(1-29)NH2 having antagonistic activity
ES2134280T3 (es) * 1994-03-21 1999-10-01 Nestle Sa Procedimiento de produccion de pilocarpina.
FR2821359B1 (fr) * 2001-02-27 2003-05-09 Sod Conseils Rech Applic L'heterocarpine, une proteine fixant le ghrh humain

Also Published As

Publication number Publication date
BR0313720A (pt) 2005-07-12
CN1787828A (zh) 2006-06-14
WO2004017987A3 (fr) 2004-04-22
CN100406037C (zh) 2008-07-30
WO2004017987A2 (fr) 2004-03-04
AU2003274281A1 (en) 2004-03-11
MXPA05002161A (es) 2005-05-23
RU2005108598A (ru) 2005-08-20
IL166461A0 (en) 2006-01-15
CA2495972A1 (fr) 2004-03-04
NZ537846A (en) 2006-08-31
AU2003274281B2 (en) 2009-02-26
FR2843697A1 (fr) 2004-02-27
JP2006501229A (ja) 2006-01-12
HK1092701A1 (zh) 2007-02-16
RU2317097C2 (ru) 2008-02-20
FR2843697B1 (fr) 2005-12-09
PL375526A1 (en) 2005-11-28
DE60328296D1 (de) 2009-08-20
KR20050059091A (ko) 2005-06-17
EP1536808B1 (de) 2009-07-08
EP1536808A2 (de) 2005-06-08

Similar Documents

Publication Publication Date Title
AR038970A1 (es) Anticuerpos anti-alfa v beta 6
UA89798C2 (ru) Стабильный водный препарат антитела в гистидинацетатном буфере
BG102983A (en) Extramembrane protein 106 polypeptide of moraxella catarrhalis, its gene sequence and application
PT1171143E (pt) Extracto peptidico de tremoco e composicao farmaceutica ou cosmetica ou nutraceutica compreendendo o referido extracto
EA200700136A1 (ru) Анти-cd154-антитела
WO2004020595A8 (en) Novel human polypeptides encoded by polynucleotides
NZ605429A (en) Therapeutic human anti-il-1r1 monoclonal antibody
IL161016A (en) Polypeptides capable of ang-2 binding
DK0682524T3 (da) Farmaceutiske præparater indeholdende et baktericid/permeabilitetsforøgende protein og et afspændingsmiddel
AU2003296330A8 (en) Hla-a1, a2 -a3,-a24,-b7,and -b44 tumor associated antigen peptides and compositions
EP1383785A4 (de) Rekombinanter, tumorspezifischer antikörper und dessen verwendung
WO1999029729A3 (en) Antagonists of neuropilin receptor function and use thereof
DK1095061T3 (da) Peptider baseret på sekvensen af humant lactoferring og deres anvendelse
EP4566622A3 (de) Dap10/dap12 fusionspolypeptide
WO2004046191A3 (en) Antibodies binding to human magic roundabout (mr), polypeptides and uses thereof for inhibition angiogenesis
DE60328296D1 (de) Heterocarpine, ein pflanzliches protein mit antikrebs eigenschaften
EE200500012A (et) Peptiid-pähine passiivne immunoteraapia ateroskleroosi raviks
WO2003063775A3 (en) Methods and compositions for the promotion of hair growth utilizing actin binding peptides
IL153557A0 (en) Antibodies and antagonists to antimicrobial peptides for the purpose of treating, inhibiting and preventing auto immune diseases
WO2001007479A3 (en) Fragments of cellular prion protein and methods useful in the diagnosis and treatment of prion diseases
EP1808179A3 (de) Verwendung von HSP20 zur Förderung der Wundheilung und/oder zur Reduzierung der Narbenbildung
EP1212340A4 (de) 29 mit krebs im zusammenhang stehende menschliche proteine
WO2004030607A3 (en) Peptide-based passive immunization therapy for treatment of atherosclerosis
WO2003004517A3 (en) Peyers's patch and/or m-celle targeting ligands
EP1489093A4 (de) Peptide, medizinische zusammensetzungen, die die peptide enthalten, und medizinische zusammensetzungen zur behandlung von krebs

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties